Clark Capital Management Group’s BIO-REFERENCE LABS INC-NEW- BRLI Stock Holding History

Clark Capital Management Group’s Portfolio BRLI Stock Details BRLI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-4,943	Closed	-$204K	–	365
2015 Q2	$204K	Sell	4,943 -8,760	-64%	-$314K	0.02%	314
2015 Q1	$483K	Sell	13,703 -892	-6%	-$30.2K	0.04%	224
2014 Q4	$469K	Buy	+14,595	New	+$422K	0.04%	209
2013 Q4	–	Sell	-15,226	Closed	-$455K	–	388
2013 Q3	$455K	Sell	15,226 -4,213	-22%	-$117K	0.04%	194
2013 Q2	$559K	Buy	+19,439	New	+$536K	0.05%	168

Other funds holding BRLI

SAM

Shell Asset Management The Hague, Netherlands $996M AUM 26.19% 1-Year Est. Return

Clark Capital Management Group's BRLI Position: Q3 2015 in Review

Clark Capital Management Group sold out of BIO-REFERENCE LABS INC-NEW- (BRLI) in Q3 2015, closing a stake of 4,943 shares — an estimated $204K sold.

Clark Capital Management Group first reported a position in BRLI in Q2 2013 and held it in 5 quarters. The position peaked at $559K in Q2 2013. 1 fund tracked by Wall St. Rank holds BRLI as of Q3 2015.

Clark Capital Management Group reported no remaining BIO-REFERENCE LABS INC-NEW- position as of Q3 2015 after selling out during the quarter.
Clark Capital Management Group sold 4,943 BIO-REFERENCE LABS INC-NEW- shares in Q3 2015, an estimated $204K.
Clark Capital Management Group first reported a position in BIO-REFERENCE LABS INC-NEW- in Q2 2013 and held it in 5 quarters.
Clark Capital Management Group's BIO-REFERENCE LABS INC-NEW- position peaked at $559K in Q2 2013.
1 fund tracked by Wall St. Rank held BIO-REFERENCE LABS INC-NEW- as of Q3 2015.

Based on Clark Capital Management Group's 13F filing for Q3 2015, filed 3 Nov 2015.